Blog

News &
Updates

Revital Exported 70 Million Covid-19 Vaccine Syringes

Revital Healthcare has been globally acknowledged for its role in exporting more than 70 million Covid-19 vaccine syringes during the pandemic. The then President of Kenya, Uhuru Kenyatta, praised the company’s contribution to being the largest producer of Covid-19 vaccine syringes on the continent during his State of the Nation address today. This has propelled the country to the top of the innovation and manufacturing industry map, according to the Head of State. The President added that this move has been instrumental in the fight against the pandemic, which has claimed millions of lives.

Revital Healthcare has taken advantage of available opportunities to create employment and fill gaps, given that the global shortage of Covid-19 vaccine syringes is estimated at 2 billion. Revital Healthcare is an Export Processing Zone (EPZ) company that is meeting the worldwide demand for syringe production. It began in 2008 with a single product and has since grown to 45 products, making it Africa’s largest medical device manufacturer. 

A Kenyan company known as Revital operating in Kilifi County in Coast region became Africa’s largest producer and exporter of COVID-19 vaccine syringes during the COVID period. This means that Revital company is able to produce one out of every ten COVID-19 vaccine syringes globally.

Uhuru Kenyatta,
President Of Kenya

In a recent development, Revital Healthcare successfully secured a highly profitable contract to supply 50 million 2ml vaccine syringes to  India. Triumphing over global competitors, the company emerged as the chosen supplier in a competitive tender, with the contract valued at Sh150 million. Moreover, it has also been awarded an additional contract, ensuring exclusive rights to produce all the 0.5ml syringes throughout 2022. As the new, more critical Covid-19 variant continues to pose a significant threat in numerous nations worldwide, Revital Healthcare plays a pivotal role in addressing the shortage of Covid-19 vaccine syringes and meeting the pressing demand.

More From This Category

WHO PQS

WHO PQS

Press ReleaseRevital Healthcare EPZ Ltd. Achieves WHO Prequalification for Early-Activation Auto-Disable Syringe: A Milestone for African Manufacturing and Immunization ProgrammingRevital Healthcare EPZ Ltd. stands as the exclusive African manufacturer granted WHO PQ...

Revital banks blanket contract from a key global organisation

Revital banks blanket contract from a key global organisation

Blog News &UpdatesRevital Healthcare banks blanket contractfrom a key global organisationRevital Healthcare has recently secured a notable contract with a global organization to supply India with 50 million units of 2ML vaccine syringes amidst concerns over a...

Ukraine using Revital-made bCPAP device to save premature babies

Ukraine using Revital-made bCPAP device to save premature babies

Blog News &UpdatesUkraine using Revital-made bCPAP device to save premature babiesPremature babies in Ukraine with breathing difficulties are being saved by a device made in Kenya. The bCPAP device, produced by Africa's largest medical manufacturer - Revital...